Biogen Pharmachem Industries Ltd
₹ 0.35
-2.78%
10 Jun
- close price
About
Incorporated in 1995, Biogen Pharmachem Industries Ltd is in the business of trading
in shares and securities.[1]
Key Points
- Market Cap ₹ 36.9 Cr.
- Current Price ₹ 0.35
- High / Low ₹ 0.93 / 0.32
- Stock P/E 42.9
- Book Value ₹ 0.94
- Dividend Yield 0.00 %
- ROCE 1.01 %
- ROE 0.90 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Stock is trading at 0.37 times its book value
Cons
- Company has a low return on equity of 1.11% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Finance Other Financial Services
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.00 | -0.00 | -0.00 | 0.11 | 0.95 | -0.00 | 1.62 | 2.47 | -0.00 | 2.38 | 1.20 | 2.56 | |
| 0.04 | 0.03 | 0.12 | 6.72 | 0.95 | 0.12 | 3.22 | 2.49 | 0.45 | 0.45 | 1.49 | 1.60 | |
| Operating Profit | -0.04 | -0.03 | -0.12 | -6.61 | -0.00 | -0.12 | -1.60 | -0.02 | -0.45 | 1.93 | -0.29 | 0.96 |
| OPM % | -6,009.09% | -0.00% | -98.77% | -0.81% | 81.09% | -24.17% | 37.50% | |||||
| -0.00 | -0.00 | -0.00 | 0.05 | -0.00 | -0.00 | -0.00 | 0.01 | 0.91 | -0.00 | -0.00 | -0.00 | |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Depreciation | 0.10 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Profit before tax | -0.14 | -0.03 | -0.12 | -6.56 | -0.00 | -0.12 | -1.60 | -0.01 | 0.46 | 1.93 | -0.29 | 0.96 |
| Tax % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 10.42% | |
| -0.13 | -0.03 | -0.12 | -6.56 | -0.00 | -0.12 | -1.60 | -0.01 | 0.46 | 1.93 | -0.29 | 0.86 | |
| EPS in Rs | -0.00 | -0.00 | -0.00 | -0.09 | -0.00 | -0.00 | -0.02 | -0.00 | 0.01 | 0.03 | -0.00 | 0.01 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | % |
| TTM: | 113% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 20% |
| 3 Years: | 85% |
| TTM: | 397% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 6% |
| 3 Years: | -15% |
| 1 Year: | -58% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 65.26 | 90.26 |
| Reserves | -4.27 | -4.30 | -4.42 | -10.98 | -10.99 | -9.51 | -11.12 | -11.13 | -10.67 | -8.74 | 26.67 | 8.83 |
| 10.00 | 6.21 | 0.72 | 0.01 | 0.63 | 0.31 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| 2.49 | 1.64 | 1.69 | 1.64 | 2.73 | 0.03 | 0.11 | 0.82 | 0.24 | 0.30 | 0.09 | 0.31 | |
| Total Liabilities | 73.48 | 68.81 | 63.25 | 55.93 | 57.63 | 56.09 | 54.25 | 54.95 | 54.83 | 56.82 | 92.02 | 99.40 |
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | 43.78 | 26.69 | 22.39 | 3.52 | 6.25 | 6.45 | 9.49 | 6.95 | 8.85 | 5.44 | 23.84 | 32.78 |
| 29.70 | 42.12 | 40.86 | 52.41 | 51.38 | 49.64 | 44.76 | 48.00 | 45.98 | 51.38 | 68.18 | 66.62 | |
| Total Assets | 73.48 | 68.81 | 63.25 | 55.93 | 57.63 | 56.09 | 54.25 | 54.95 | 54.83 | 56.82 | 92.02 | 99.40 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.28 | 4.68 | -0.07 | -13.65 | 0.09 | -1.21 | 3.95 | 1.40 | 1.70 | 1.94 | -1.08 | 1.57 | |
| 17.08 | 17.08 | 4.30 | 14.32 | -0.72 | 1.54 | -3.64 | -1.32 | -1.66 | -2.06 | -32.62 | -9.56 | |
| -11.19 | -21.74 | -4.31 | -0.71 | 0.62 | -0.32 | -0.31 | -0.00 | -0.00 | -0.00 | 35.70 | 6.30 | |
| Net Cash Flow | -1.38 | 0.02 | -0.07 | -0.03 | -0.02 | -0.00 | -0.00 | 0.08 | 0.05 | -0.11 | 2.00 | -1.69 |
| Free Cash Flow | -7.28 | 4.68 | -0.07 | -13.65 | 0.09 | -1.21 | 3.95 | 1.40 | 1.70 | 1.94 | -1.08 | 1.57 |
| CFO/OP | 18,200% | -15,600% | 58% | 207% | 1,008% | -247% | -7,000% | -378% | 101% | 372% | 164% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 23,326.82 | 3,085.21 | 572.28 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Inventory Days | -0.00 | -0.00 | -0.00 | |||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 23,326.82 | 3,085.21 | 572.28 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Working Capital Days | 23,194.09 | 2,651.05 | 549.75 | 152.21 | -35.27 | 170.33 | -19.96 | |||||
| ROCE % | -0.15% | -0.04% | -0.19% | -11.32% | -0.00% | -0.22% | -2.90% | -0.02% | -0.37% | 3.47% | -0.39% | 1.01% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income on Loans INR |
|
||||||||||
| Number of Companies in Investment Portfolio Number |
|||||||||||
| Revenue Generating Activity - Sales INR |
|||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
23 May - Biogen Pharmachem filed Annual Secretarial Compliance Report for FY2025-26, noting compliance with no major violations.
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
20 May - Rama Shiva Lease Finance cut Biogen stake from 9.31% to 4.04% on 18 May 2026.
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
20 May - Rama Shiva Lease Finance sold 4.75 crore shares; stake fell from 9.31% to 4.04% on 18 May 2026.
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
20 May - Parichay Infrastructure sold/acquired 3.99 crore shares in Biogen on 18 May 2026; holding fell to 4.66%.
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
19 May - Interface Financial Services sold 4,03,03,000 Biogen shares on 18.05.2026; holding fell to 4.84%.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
BPIL is engaged in the business of trading in shares and securities in the present and future markets. It trades in commodities, including agro-based and precious metals, and other goods. The company also provides stock broking and consulting services. In addition, it generates trades and sells wind power